Teladoc Health (TDOC) Stock Price, News & Analysis

Company Overview

Teladoc Health, Inc. (NYSE: TDOC) provides virtual healthcare services and technology that connect patients with physicians, therapists and other healthcare professionals. Its platform supports general medical care, specialist consultations, mental health services, chronic condition management and related healthcare programs through digital and remote-care channels.

The company’s offerings include Teladoc’s telehealth services, BetterHelp’s online counseling and therapy platform, and chronic care solutions developed through Livongo, which Teladoc acquired in 2020. Teladoc serves individuals, employers, health plans, hospitals and other healthcare organizations, helping them deliver care through mobile devices, computers and connected health technologies.

Founded in 2002, Teladoc helped establish telemedicine as a mainstream healthcare delivery model and expanded through organic growth and acquisitions. The company serves patients and healthcare customers in the United States and international markets. Charles “Chuck” Divita became Teladoc Health’s chief executive officer in 2024.

Key Stats

• Today's Range: $5.88 to $6.18
• 50-Day Range: $5.52 to $7.12
• 52-Week Range: $4.40 to $9.89
• Volume: 3.16 million shs
• Average Volume: 5.09 million shs
• Market Capitalization: $1.09 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.54
• Consensus Rating: Hold

Teladoc Health Stock Analysis - MarketRank™

Teladoc Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 394th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 5 buy ratings, 10 hold ratings, and 1 sell rating.

Upside Potential

Teladoc Health has a consensus price target of $7.54, representing about 23.0% upside from its current price of $6.13.

Amount of Analyst Coverage

Teladoc Health has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Teladoc Health are expected to grow in the coming year, from ($0.92) to ($0.76) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teladoc Health is -6.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teladoc Health is -6.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Teladoc Health has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.68% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 8.93.

Change versus previous month

Short interest in Teladoc Health has recently increased by 8.96%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Teladoc Health does not currently pay a dividend.

Dividend Growth

Teladoc Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.78

News Sentiment

Teladoc Health has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Teladoc Health this week, compared to 8 articles on an average week.

Search Interest

10 people have searched for TDOC on MarketBeat in the last 30 days. This is an increase of 233% compared to the previous 30 days.

MarketBeat Follows

3 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $112,311.00 in company stock.

Percentage Held by Insiders

0.70% of the stock of Teladoc Health is held by insiders.

Percentage Held by Institutions

76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 10/13/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NYSE:TDOC
• CIK: 1477449
• Web: www.teladochealth.com
• Phone: (203) 635-2002
• Fax: N/A
• Employees: 5,600
• Year Founded: 2002

Price Target and Rating

• Average Price Target for Teladoc Health: $7.54
• High Price Target: $11.00
• Low Price Target: $5.00
• Potential Upside/Downside: +25.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.99)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$200.32 million
• Net Margins: -7.13%
• Pretax Margin: -7.33%
• Return on Equity: -12.15%
• Return on Assets: -5.83%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.83
• Quick Ratio: 0.81

Sales & Book Value

• Annual Sales: $2.53 billion
• Price / Sales: 0.43
• Cash Flow: $1.88 per share
• Price / Cash Flow: 3.20
• Book Value: $7.81 per share
• Price / Book: 0.77

Miscellaneous

• Outstanding Shares: 181,680,000
• Free Float: 180,412,000
• Market Cap: $1.09 billion
• Optionable: Optionable
• Beta: 2.14